Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections.
about
Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization BreadthSomatic hypermutations confer rheumatoid factor activity in hepatitis C virus-associated mixed cryoglobulinemiaThe promise and challenge of high-throughput sequencing of the antibody repertoire.High-quality full-length immunoglobulin profiling with unique molecular barcoding.In-Depth Assessment of Within-Individual and Inter-Individual Variation in the B Cell Receptor Repertoire.Molecular signature in HCV-positive lymphomasAn elaborate landscape of the human antibody repertoire against enterovirus 71 infection is revealed by phage display screening and deep sequencing.Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII).Differentially regulated gene expression associated with hepatitis C virus clearance.Lineage tracing of human B cells reveals the in vivo landscape of human antibody class switching.HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic role.Novel E2 Glycoprotein Tetramer Detects Hepatitis C Virus-Specific Memory B Cells.Next-generation approaches to advancing eco-immunogenomic research in critically endangered primates.Reproducibility and Reuse of Adaptive Immune Receptor Repertoire Data.Analyzing Immunoglobulin Repertoires.The in Vitro Antigenicity of Plasmodium vivax Rhoptry Neck Protein 2 (PvRON2) B- and T-Epitopes Selected by HLA-DRB1 Binding Profile.
P2860
Q27676728-A83F8F11-4E8F-4CA1-A3E4-F10DBEA29A9AQ33634440-D189845A-3A49-420D-94E0-02C49EC3EA7FQ33962293-F3E6E8E4-090B-4F63-9554-619205B6B0E2Q36094995-E4A77190-A51D-4E56-898F-751AB344A60EQ36147360-66EAF690-7D98-4958-8CA2-0BECA3F82CD4Q36199986-FC2920AB-0C47-44C5-AD25-9CDBB62BB575Q36215765-D8FA4F7A-CE9A-45BF-9518-0B0C32514030Q36432725-2B0A47FB-89B7-4993-B968-CF5428D357F2Q37006700-1D5FBA96-AE76-49EE-8A6F-43673ECC848EQ37146773-92A71931-A88B-4784-ABB4-061E24A621C1Q38018062-C59C37DB-33F4-4801-961F-0088E32AFBF1Q40449975-0B8C02B2-0866-495E-9D34-5894C35FDE09Q41385592-273F64E2-ADF6-45FA-8E8E-6A8A7A3A7F8AQ45951472-A4D6CA68-1212-4A10-AFBE-CE0DE5129CE6Q52723424-3647822F-E294-4CB7-9FDE-7AE4B1EBBA70Q55380572-F869FA47-8357-4A29-A7E6-7525167EE131
P2860
Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Antibody V
@nl
Antibody V(h) repertoire diffe ...... hepatitis C virus infections.
@ast
Antibody V(h) repertoire diffe ...... hepatitis C virus infections.
@en
type
label
Antibody V
@nl
Antibody V(h) repertoire diffe ...... hepatitis C virus infections.
@ast
Antibody V(h) repertoire diffe ...... hepatitis C virus infections.
@en
prefLabel
Antibody V
@nl
Antibody V(h) repertoire diffe ...... hepatitis C virus infections.
@ast
Antibody V(h) repertoire diffe ...... hepatitis C virus infections.
@en
P2093
P2860
P50
P1433
P1476
Antibody V(h) repertoire diffe ...... hepatitis C virus infections.
@en
P2093
Claudia Brunetti
Franco Dammacco
Laura Caggiari
Mariangela De Zorzi
Patrizia Leone
Valli De Re
P2860
P304
P356
10.1371/JOURNAL.PONE.0025606
P407
P577
2011-09-28T00:00:00Z